Moreover, TMEFF2 is an AR-regulated (Overcash et al, 2013) PCa-specific transmembrane protein (Gery et al, 2002) that is being targeted with a BiTE in chemotherapy or ARPI-refractory mCRPC (NCT04898634). Here, AR is linked to posterior cortical atrophy.